Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Aardvark Therapeutics, Inc. - Common Stock (NQ:AARD)

10.44 +0.30 (+2.96%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 10, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 133,524
Open 10.21
Bid (Size) 9.000 (100)
Ask (Size) 10.98 (600)
Prev. Close 10.14
Today's Range 10.12 - 10.68
52wk Range 4.880 - 19.58
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
This Aardvark Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Friday
 
Via Benzinga
Aardvark Therapeutics Presents Data Supporting its Metabolic Obesity Pipeline Programs at ObesityWeek 2025
From Aardvark Therapeutics, Inc.
Via GlobeNewswire

Performance

YTD
-27.0%
-27.0%
1 Month
-28.6%
-28.6%
3 Month
-6.4%
-6.4%
6 Month
-4.8%
-4.8%
1 Year
-27.0%
-27.0%

More News

Read More
Aardvark Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
From Aardvark Therapeutics, Inc.
Via GlobeNewswire
Aardvark Therapeutics to Present at Upcoming Investor Conferences in November
From Aardvark Therapeutics, Inc.
Via GlobeNewswire
Aardvark Therapeutics to Present Data on Pipeline Programs at Upcoming ObesityWeek
From Aardvark Therapeutics, Inc.
Via GlobeNewswire
Aardvark Therapeutics Announces FDA Alignment on Protocol Amendment Expanding Phase 3 HERO Trial Population for Prader-Willi Syndrome
From Aardvark Therapeutics, Inc.
Via GlobeNewswire
This Coinbase Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
Via Benzinga
Aardvark Therapeutics to Present at the Stifel 2025 Virtual Cardiometabolic Forum
From Aardvark Therapeutics, Inc.
Via GlobeNewswire
Aardvark Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
From Aardvark Therapeutics, Inc.
Via GlobeNewswire
Aardvark Therapeutics to Present at Upcoming Investor Conferences in September
From Aardvark Therapeutics, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Aardvark Therapeutics Reports Q2 Loss
Via The Motley Fool
Aardvark Therapeutics Reports Second Quarter 2025 Financial Results and Provides Pipeline and Business Updates
From Aardvark Therapeutics, Inc.
Via GlobeNewswire
Aardvark Therapeutics Announces ARD-201 Preclinical Obesity Data Showing Significant Weight Loss as a Monotherapy, Enhancement of GLP-1RA Therapy in Combination, and Effective Maintenance Following Discontinuation of GLP-1RA Therapy
From Aardvark Therapeutics, Inc.
Via GlobeNewswire
Aardvark Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(C)(4)
From Aardvark Therapeutics, Inc.
Via GlobeNewswire
Aardvark's Hunger-Suppressing Drug Promises Weight Loss Without GI Distress
Via Benzinga
Topics Initial Public Offering
Aardvark Therapeutics to Join Prader-Willi Syndrome Community at the 2025 United in Hope Conference
From Aardvark Therapeutics, Inc.
Via GlobeNewswire
Aardvark Therapeutics Bolsters Leadership Team with Strategic Hires Across Scientific, Commercial, Regulatory and Legal Functions
From Aardvark Therapeutics, Inc.
Via GlobeNewswire
These stocks are gapping in today's session
Via Chartmill
Aardvark Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Highlights
From Aardvark Therapeutics, Inc.
Via GlobeNewswire
Aardvark Therapeutics to Present at Upcoming Investor Conferences in May
From Aardvark Therapeutics, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Why United Airlines Shares Are Trading Higher By Over 6%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Aardvark Therapeutics Reports Full Year 2024 Financial Results and Provides Business Highlights
From Aardvark Therapeutics, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Aardvark Therapeutics, Inc. - Common Stock publicly traded?
Yes, Aardvark Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Aardvark Therapeutics, Inc. - Common Stock trade on?
Aardvark Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Aardvark Therapeutics, Inc. - Common Stock?
The ticker symbol for Aardvark Therapeutics, Inc. - Common Stock is AARD on the Nasdaq Stock Market
What is the current price of Aardvark Therapeutics, Inc. - Common Stock?
The current price of Aardvark Therapeutics, Inc. - Common Stock is 10.44
When was Aardvark Therapeutics, Inc. - Common Stock last traded?
The last trade of Aardvark Therapeutics, Inc. - Common Stock was at 11/10/25 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.